Skip to main content
OpenTrials
Completed

NCT Number: NCT05204745

Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten

Idiopathic normal pressure hydrocephalus (INPH) is a treatable disease of the elderly, typically causing gait impariment, dementia and urinary incontinence. The objective of this study is to make an epidemiological survey of INPH in Umeå, Sweden. Subjects with self-perceived gait impairments will be identified through a questionnaire. They will go through clinical examinations and have an MRI of the brain. A control population will also be investigated to enable comparisons between the populations. The main hypothesis is that the prevalence of INPH in the population is higher than what is previoulsy known.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Living in Umeå, Sweden.

Exclusion criteria

  • Age <65 or >84 years when the questionnaire was sent out.
  • Death at the time for the clinical evaluation.

Treatment and study plan

Primary outcomes

  1. Number of participants with Idiopathic Normal Pressure Hydrocephalus

    Time frame: Through study completion, an average of approximately 1 month.

    Diagnosis of INPH based on clinical evaluation and MRI.

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Collaborators

  • Region Västerbotten

Registry information

Official study title

Gait and Balance Impairment, Dementia and Wide Brain Ventricles in the Ages 65-84 Years

Acronym: VESPR

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Jan 24, 2022
Registry last updated
Jan 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.